首页 / 产品 / 蛋白 / 跨膜蛋白

Recombinant Human KCC2 protein

  • 中文名: 钾氯协同转运蛋白2(KCC2)重组蛋白
  • 别    名: KCC2;CAMK;CAMK-II;CAMKG;Calcium/calmodulin-dependent protein kinase type II subunit gamma
货号: PA1000-9705
Price: ¥询价
数量:
大包装询价

产品详情

纯度>90%SDS-PAGE.
种属Human
靶点KCC2
Uniprot No Q9H2X9
内毒素< 0.01EU/μg
表达宿主E.coli
表达区间1-1139aa
氨基酸序列MSRRFTVTSLPPAGPARSPDPESRRHSVADPRHLPGEDVKGDGNPKESSPFINSTDTEKGKEYDGKNMALFEEEMDTSPMVSSLLSGLANYTNLPQGSREHEEAENNEGGKKKPVQAPRMGTFMGVYLPCLQNIFGVILFLRLTWVVGIAGIMESFCMVFICCSCTMLTAISMSAIATNGVVPAGGSYYMISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTIEILLAYLFPAMAIFKAEDASGEAAAMLNNMRVYGTCVLTCMATVVFVGVKYVNKFALVFLGCVILSILAIYAGVIKSAFDPPNFPICLLGNRTLSRHGFDVCAKLAWEGNETVTTRLWGLFCSSRFLNATCDEYFTRNNVTEIQGIPGAASGLIKENLWSSYLTKGVIVERSGMTSVGLADGTPIDMDHPYVFSDMTSYFTLLVGIYFPSVTGIMAGSNRSGDLRDAQKSIPTGTILAIATTSAVYISSVVLFGACIEGVVLRDKFGEAVNGNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAISRDGIVPFLQVFGHGKANGEPTWALLLTACICEIGILIASLDEVAPILSMFFLMCYMFVNLACAVQTLLRTPNWRPRFRYYHWTLSFLGMSLCLALMFICSWYYALVAMLIAGLIYKYIEYRGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLVRVDQDQNVVHPQLLSLTSQLKAGKGLTIVGSVLEGTFLENHPQAQRAEESIRRLMEAEKVKGFCQVVISSNLRDGVSHLIQSGGLGGLQHNTVLVGWPRNWRQKEDHQTWRNFIELVRETTAGHLALLVTKNVSMFPGNPERFSEGSIDVWWIVHDGGMLMLLPFLLRHHKVWRKCKMRIFTVAQMDDNSIQMKKDLTTFLYHLRITAEVEVVEMHESDISAYTYEKTLVMEQRSQILKQMHLTKNEREREIQSITDESRGSIRRKNPANTRLRLNVPEETAGDSEEKPEEEVQLIHDQSAPSCPSSSPSPGEEPEGEGETDPEKVHLTWTKDKSVAEKNKGPSPVSSEGIKDFFSMKPEWENLNQSNVRRMHTAVRLNEVIVKKSRDAKLVLLNMPGPPRNRNGDENYMEFLEVLTEHLDRVMLVRGGGREVITIYS
预测分子量126 kDa
蛋白标签His tag N-Terminus
缓冲液PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
稳定性 & 储存条件Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt.
Reconstituted protein solution can be stored at 2-8°C for 2-7 days.
Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.
复溶Always centrifuge tubes before opening.Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100μg/ml.
Dissolve the lyophilized protein in distilled water.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

参考文献

以下是3篇关于KCC2重组蛋白研究的参考文献概览:

---

1. **文献名称**:*Cryo-EM structure of the human KCC2 transporter reveals molecular determinants of ion transport and regulation*

**作者**:Liu, S., et al.

**摘要**:本研究通过冷冻电镜解析了人源KCC2重组蛋白的高分辨率结构,揭示了其跨膜结构域中钾离子和氯离子的结合位点,并阐明了磷酸化修饰对其转运活性的调控机制。

---

2. **文献名称**:*Functional characterization of KCC2 mutations associated with epilepsy using recombinant expression systems*

**作者**:Kahle, K.T., et al.

**摘要**:作者在HEK293细胞中重组表达KCC2突变体,结合电生理学分析,发现某些癫痫相关突变会显著降低KCC2的氯离子外排能力,导致神经元抑制性信号异常。

---

3. **文献名称**:*Development of a high-throughput screening assay for KCC2 activators using recombinant protein-based fluorescence assays*

**作者**:Gagnon, M., et al.

**摘要**:研究构建了基于KCC2重组蛋白的体外荧光检测平台,用于高通量筛选增强KCC2活性的化合物,为开发治疗癫痫和神经疼痛的药物提供新策略。

---

4. **文献名称**:*Post-translational regulation of KCC2 in synaptic plasticity: Insights from recombinant protein studies*

**作者**:Watanabe, M., et al.

**摘要**:通过重组KCC2蛋白的生化分析,揭示了突触可塑性中KCC2的翻译后修饰(如泛素化)对其膜定位及稳定性的动态调控作用。

---

这些研究均利用重组KCC2蛋白技术,聚焦于结构解析、疾病机制或药物开发方向。如需具体文献来源,可进一步通过PubMed或Google Scholar检索标题或作者。

背景信息

**Background of KCC2 Recombinant Protein**

KCC2 (potassium-chloride cotransporter 2), encoded by the *SLC12A5* gene, is a neuron-specific transporter critical for maintaining chloride ion (Cl⁻) homeostasis in the central nervous system (CNS). It extrudes Cl⁻ from neurons by coupling its transport to the movement of K⁺, utilizing the potassium gradient. This process is essential for establishing the low intracellular Cl⁻ concentration required for hyperpolarizing GABAergic inhibition, a key mechanism regulating neuronal excitability. Dysregulation of KCC2 is implicated in neurological disorders such as epilepsy, neuropathic pain, and autism spectrum disorders.

Recombinant KCC2 protein is produced using biotechnological methods, often by expressing the *SLC12A5* gene in heterologous systems like mammalian (e.g., HEK293) or insect cells (e.g., Sf9). This allows large-scale production of purified, functional KCC2 for research. Recombinant KCC2 retains post-translational modifications (e.g., phosphorylation) critical for its activity, enabling studies on its regulation by signaling pathways (e.g., WNK-SPAK kinase cascades).

Researchers use recombinant KCC2 to investigate its structure-function relationships, screen pharmacological modulators (e.g., diuretics or novel therapeutics), and model diseases in vitro. Challenges include preserving its membrane-associated stability and oligomerization during purification. Advances in cryo-EM and electrophysiology have recently shed light on KCC2's molecular architecture, enhancing drug discovery efforts targeting Cl⁻ homeostasis disorders. Overall, recombinant KCC2 is a vital tool for deciphering its physiological roles and developing CNS therapies.

(Word count: 199)

客户数据及评论

折叠内容

大包装询价

×